Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Adamis Pharmaceuticals CorpFinancial_Report.xls
10-Q - QUARTERLY REPORT - Adamis Pharmaceuticals Corpadamis_10q-123111.htm
EX-32.2 - 906 CERTIFICATION OF THE CFO - Adamis Pharmaceuticals Corpex-32_2.htm
EX-10.1 - THIRD AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT - Adamis Pharmaceuticals Corpex-10_1.htm
EX-31.1 - 302 CERTIFICATION OF THE CEO - Adamis Pharmaceuticals Corpex-31_1.htm
EX-31.2 - 302 CERTIFICATION OF THE CFO - Adamis Pharmaceuticals Corpex-31_2.htm


EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
 
The undersigned, Dennis J. Carlo, the Chief Executive Officer of Adamis Pharmaceuticals Corporation (the “Company”), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:
 
 
(1)
the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
     
 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 14, 2011
By:
/s/ Dennis J. Carlo
   
Dennis J. Carlo
   
Chief Executive Officer

This certification is being furnished to the SEC with this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.